AU657488B2 - New recombinant herpes viruses, a vaccine based on these recombinants, their preparation process, genes, vectors and plasmids used in this process - Google Patents

New recombinant herpes viruses, a vaccine based on these recombinants, their preparation process, genes, vectors and plasmids used in this process

Info

Publication number
AU657488B2
AU657488B2 AU83708/91A AU8370891A AU657488B2 AU 657488 B2 AU657488 B2 AU 657488B2 AU 83708/91 A AU83708/91 A AU 83708/91A AU 8370891 A AU8370891 A AU 8370891A AU 657488 B2 AU657488 B2 AU 657488B2
Authority
AU
Australia
Prior art keywords
recombinants
genes
vectors
herpes viruses
plasmids used
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU83708/91A
Other versions
AU8370891A (en
Inventor
Matthew Mckinley Binns
Arielle Rey-Senelonge
Michel Emile Albert Riviere
Louis Joseph Norman Ross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health USA Inc
Original Assignee
Rhone Merieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Merieux SA filed Critical Rhone Merieux SA
Publication of AU8370891A publication Critical patent/AU8370891A/en
Application granted granted Critical
Publication of AU657488B2 publication Critical patent/AU657488B2/en
Assigned to MERIAL reassignment MERIAL Request to Amend Deed and Register Assignors: RHONE MERIEUX
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU83708/91A 1990-09-07 1991-09-06 New recombinant herpes viruses, a vaccine based on these recombinants, their preparation process, genes, vectors and plasmids used in this process Ceased AU657488B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR909011146A FR2666589B1 (en) 1990-09-07 1990-09-07 NOVEL RECOMBINANT HERPIC VIRUSES, VACCINE BASED ON SUCH RECOMBINANTS, PREPARATION METHOD THEREOF, GENES, VECTORS AND PLASMIDS USED IN THIS PROCESS.
FR9011146 1990-09-07

Publications (2)

Publication Number Publication Date
AU8370891A AU8370891A (en) 1992-03-12
AU657488B2 true AU657488B2 (en) 1995-03-16

Family

ID=9400177

Family Applications (1)

Application Number Title Priority Date Filing Date
AU83708/91A Ceased AU657488B2 (en) 1990-09-07 1991-09-06 New recombinant herpes viruses, a vaccine based on these recombinants, their preparation process, genes, vectors and plasmids used in this process

Country Status (5)

Country Link
EP (1) EP0477056A1 (en)
JP (1) JPH05168473A (en)
AU (1) AU657488B2 (en)
CA (1) CA2050850A1 (en)
FR (1) FR2666589B1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928648A (en) * 1985-09-06 1999-07-27 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
US5965138A (en) * 1985-09-06 1999-10-12 Syntro Corporation Recombinant chimeric virus and uses thereof
US6087127A (en) * 1990-08-24 2000-07-11 Board Of Trustees Operating Michigan State University Marek's disease herpesvirus DNA segment encoding glycoproteins, gD, gI and gE
US5849571A (en) * 1990-10-10 1998-12-15 University Of Pittsburgh Of The Commonwealth System Of Higher Education Latency active herpes virus promoters and their use
US5849572A (en) * 1990-10-10 1998-12-15 Regents Of The University Of Michigan HSV-1 vector containing a lat promoter
US5849299A (en) * 1991-06-28 1998-12-15 The United States Of America As Represented By The Secretary Of Agriculture Attenuated revertant serotype 1 marek's disease vaccine
US5853733A (en) * 1993-02-26 1998-12-29 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
ES2187508T3 (en) 1992-07-30 2003-06-16 Akzo Nobel Nv VACCINES VECTORS OF HERPES VIRUS FELINO RECOMBINED.
US6875856B2 (en) 1993-09-24 2005-04-05 Syntro Corporation Recombinant infectious laryngotracheitis virus and uses thereof
FR2719056B1 (en) * 1994-04-20 1996-09-06 Rhone Merieux Herpesvirus transformed to express gD in vitro.
FR2728795B1 (en) * 1994-12-30 1997-03-21 Rhone Merieux AVIAN RECOMBINANT LIVING VACCINE USING AVIAN HERPES VIRUS AS A VECTOR
AU4489896A (en) * 1994-12-30 1996-07-24 Rhone Merieux Avian recombinant live vaccine
FR2728794B1 (en) * 1994-12-30 1997-03-21 Rhone Merieux AVIAN RECOMBINANT VACCINE BASED ON AVIAN HERPES VIRUS, PARTICULARLY AGAINST GUMBORO DISEASE
FR2757061B1 (en) * 1996-12-16 1999-03-26 Rhone Merieux AVIAN RECOMBINANT LIVING VACCINE USING AVIAN INFECTIOUS LARYNGOTRACHEITIS VIRUS AS A VECTOR
CA2851658C (en) 2011-10-21 2022-03-15 Intervet International B.V. Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens
BR112014008161A2 (en) 2011-10-21 2017-04-11 Intervet Int Bv recombinant non-pathogenic marek's disease virus, method for preparing it, nucleic acid molecule, host cell, poultry vaccine, method for preparing a vaccine, use of a recombinant non-pathogenic marek's disease virus, and , poultry vaccination method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8143791A (en) * 1990-07-30 1992-02-06 Intervet International B.V. Recombinant marek's disease virus
AU619812B2 (en) * 1988-03-20 1992-02-06 Research Foundation For Microbial Diseases Of Osaka University, The A recombinant marek's disease virus and a vaccine
AU633663B2 (en) * 1989-12-04 1993-02-04 Intervet International B.V. Recombinant herpesvirus of turkeys and live vector vaccines derived thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL91627A (en) * 1988-09-13 1995-08-31 Rhone Merieux Viral nucleotide sequences

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU619812B2 (en) * 1988-03-20 1992-02-06 Research Foundation For Microbial Diseases Of Osaka University, The A recombinant marek's disease virus and a vaccine
AU633663B2 (en) * 1989-12-04 1993-02-04 Intervet International B.V. Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
AU8143791A (en) * 1990-07-30 1992-02-06 Intervet International B.V. Recombinant marek's disease virus

Also Published As

Publication number Publication date
FR2666589B1 (en) 1994-08-05
FR2666589A1 (en) 1992-03-13
CA2050850A1 (en) 1992-03-08
AU8370891A (en) 1992-03-12
EP0477056A1 (en) 1992-03-25
JPH05168473A (en) 1993-07-02

Similar Documents

Publication Publication Date Title
AU657488B2 (en) New recombinant herpes viruses, a vaccine based on these recombinants, their preparation process, genes, vectors and plasmids used in this process
USD361382S (en) Dental material curing apparatus
GB2246784B (en) Herpes virus recombinant poxvirus vaccine
AU4325089A (en) Viral vaccines
GB2210621B (en) Two micron yeast plasmid vector
AU2371692A (en) Recombinant hepatitis a virus vaccine
AU1768192A (en) Rna delivery vector
AU7097494A (en) Envelope fusion vectors for use in gene delivery
EP0299242A3 (en) Heterologous viral peptide particle immunogens
AU2497292A (en) Flavivirus envelope proteins with increased immunogenicity for use in immunization against virus infection
AU3636189A (en) Hiv-2 virus variants
AU600130B2 (en) New, color pure iron oxide pigments, a process for their preparation and their use
AU1927797A (en) Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines
OA09664A (en) Virus/herbicide-resistance genes, processes for the preparation thereof and the use thereof
AU5848390A (en) Self-assembled, defective, non-self-propagating viral particles
AU5350990A (en) Vaccinia vectors, vaccinia genes and expression products thereof
AU7138091A (en) Fluorourethane group-containing polymers made from ethylenically unsaturated monomers, process for their preparation and their use
AU6358190A (en) Polypeptide vaccines against foot-and-mouth disease virus
ZA907656B (en) A dna sequence,an anther-specific promoter and the use thereof
AU5836390A (en) Human lymphoma-associated virus
CA2148369A1 (en) Actinobacillus pleuropneumoniae outer membrane lipoprotein a and uses thereof
AU3232995A (en) Hepatitis a virus deletion mutants and vaccine formulations containing the same
GB8919102D0 (en) A recombinant adenovirus dna sequence,a recombinant adenovirus expressing the dna sequence and a rhabdovirus vaccine including the recombinant adenovirus
AU4569393A (en) Anti-feline immunodeficiency virus (fiv) vaccines
HU9203976D0 (en) Vaccine based on modified herpes virus

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired